A5038648114- Cancer Immunotherapy and Biomarkers
- Gallbladder and Bile Duct Disorders
- Head and Neck Cancer Studies
- Breast Cancer Treatment Studies
- Biliary and Gastrointestinal Fistulas
- Ferroptosis and cancer prognosis
- Lung Cancer Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Esophageal and GI Pathology
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Immunotherapy and Immune Responses
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal Cancer Research and Treatment
- Prostate Cancer Treatment and Research
- Colorectal and Anal Carcinomas
- Colorectal Cancer Treatments and Studies
Hospital Del Mar
2018-2024
Centro de Investigación Biomédica en Red de Cáncer
2022
Hospital del Mar Research Institute
2021-2022
Municipal Institute for Medical Research
2021
ORCID
2021
Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported multiple studies. However, inconsistent results incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controversy regarding the concept HPD.Consecutive patients treated nivolumab (N = 42) or docetaxel 37) were evaluated. HPD was quantified by applying three methods (tumor growth rate [TGR], tumor kinetics [TGK], Response...
Immunotherapy has been shown to provide clinical benefit in selected patients with head and neck squamous cell carcinoma (HNSCC), regardless of human papillomavirus (HPV) infection, including recurrent/metastatic (R/M) platinum refractory tumors. Hyperprogression is an uncommon negative outcome treatment immunotherapy. We present the case a patient HPV+ HNSCC who presented hyperprogression after immunotherapy rare metastasis location peritoneal carcinomatosis subcutaneous nodules. related...
Abstract Background: Pancreatic cancer (PCa) and biliary tract carcinomas (BTCa) have high morbidity mortality rates. Bile duct obstruction (BDO) develops in approximately 65–75% of PCa at diagnosis, delaying the administration an optimal treatment. In patients not candidates for surgery, BDO is usually treated through endoscopy-guided placement self-expanding stents bile duct. Methods: this retrospective study, we sought to describe clinical characteristics outcomes a cohort with malignant...